News

China Pharma has received approval from the Chinese State Food and Drug Administration (SFDA) for the production of generic – Omeprazole Sodium injections. Omeprazole is indicated for the

Sinovac has reported positive top-line results from the completed clinical trial for its H1N1 vaccine. In the study, a total of 1,614 participants over three years old received

Xceleron has signed a second Master Service Agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Xceleron will provide analytical support to GSK and its affiliated research

Strategic Diagnostics (SDI) has bagged US Patent No. 7521201 B2 for using bacteriophages in microbiological assay tests and processes. The invention is a rapid bacterial detection method that

AstraZeneca Canada has filed a New Drug Submission (NDS) for FluMist (Influenza Vaccine, Live Attenuated Intranasal) with Health Canada. AstraZeneca Canada intends to bring MedImmune’s vaccine technology to

Kolltan Pharmaceuticals has raised an additional $5m to close its Series A financing at $40m. Participants in the Series A financing include Purdue Pharma, LP, HBM BioCapital LP,

Adamas Pharmaceuticals has entered into a co-operative R&D agreement (CRADA) with the US Naval Health Research Center. The deal is for preclinical studies evaluating Adamas’ triple combination antiviral

Basilea Pharmaceutica said that the US FDA has issed a warning letter to Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) related to ceftobiprole clinical trials, for the

BioNeutral Group, a specialty chemical technology-based Life Science company, has revealed the independent lab test results conducted at Microbiotest of Sterling, Virginia. The results demonstrated that Ygiene Hospital